Community-acquired pneumonia (CAP) continues to be an important infectious cause of morbidity and mortality. 1 The selection of appropriate antibiotics for its treatment depends on several factors such as antimicrobial resistance, susceptibility, and guideline recommendations. 2 Ceftaroline fosamil has shown antibacterial activity against many pathogens associated with CAP.
2,3 The present infographic illustrates the efficacy of Ceftaroline Fosamil in the management of CAP. PP-ZFO-IND-0100 05 Aug 2020
